Extrahepatic Bile Duct Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - nci_ncicdr0000258011-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Extrahepatic Bile Duct Cancer Treatment
Salivary Gland Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Salivary Gland Cancer
Note: Some citations in the text of this section are followed by a level of evidence. The PDQ editorial boards use a formal ranking system to help the reader judge the strength of evidence linked to the reported results of a therapeutic strategy. (Refer to the PDQ summary on Levels of Evidence for more information.) Related Summaries Note: Other PDQ summaries containing information related to ...
Endometrial Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Risks of Endometrial Cancer Screening
Screening tests have risks. Decisions about screening tests can be difficult. Not all screening tests are helpful and most have risks. Before having any screening test,you may want to discuss the test with your doctor. It is important to know the risks of the test and whether it has been proven to reduce the risk of dying from cancer. The risks of endometrial cancer screening tests include ..
AIDS-Related Lymphoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - AIDS-Related Peripheral / Systemic Lymphoma
The treatment of acquired immunodeficiency syndrome (AIDS)-related lymphomas involves overcoming several problems. These are all aggressive lymphomas,which by definition are diffuse large cell/immunoblastic lymphoma or small noncleaved cell lymphoma. These lymphomas frequently involve the bone marrow and central nervous system and,therefore,are usually in an advanced stage. In addition,the ...
Ewing’s tumors of bone and soft tissues belong to the group of neoplasms commonly referred to as small round blue cell tumors of childhood. The MIC2 gene product,CD99,is a surface membrane protein that is expressed in most cases of Ewing’s sarcoma/primitive neuroectodermal tumor (PNET) family of tumors and is useful in the diagnosis of these tumors when the results are interpreted in the ...
Cancer Genetics Overview (PDQ®): Genetics - Health Professional Information [NCI] - Introduction
How to use the National Cancer Institute (NCI's) dictionary of genetic terms.
Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®): Supportive care - Health Professional Information [NCI] - Posttransplantation Dental Treatment
Posttransplantation Dental Treatment
Treatment Options for Recurrent Endometrial Cancer
Treatment of recurrent endometrial cancer may include the following: Radiation therapy as palliative therapy to relieve symptoms and improve the patient’s quality of life. Hormone therapy. Clinical trials of chemotherapy. This summary section refers to specific treatments under study in clinical trials,but it may not mention every new treatment being studied. Information about ongoing ...
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Plasma Cell Neoplasms
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer,there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you. Multiple Myeloma Patients without symptoms may not need treatment. When symptoms appear,the treatment of multiple myeloma may be done in phases: ...
Testicular Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - About This PDQ Summary
PURPOSE OF THIS SUMMARY This PDQ cancer information summary for health professionals provides comprehensive,peer-reviewed,evidence-based information about the treatment of testicular cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions. REVIEWERS AND UPDATES ...